Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lonza Launches Capsugel Zephyr DPI Portfolio | Contract Pharma

What are you searching for?

Sign in
Breaking News

Lonza Launches Capsugel Zephyr DPI Portfolio

Includes a portfolio of high-quality, customizable DPI capsules of different polymers and compositions, and product customization services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza has launched Capsugel Zephyr, a new dry-powder inhalation (DPI) capsule portfolio for customized solutions for optimal pulmonary drug delivery. Lonza’s Capsule Delivery Solutions developed Capsugel Zephyr capsules as a portfolio of high-quality, highly customizable DPI capsules of different polymers and compositions, and product customization services to help address the specific needs of inhalation drug products manufacturers.

 

“Capsule-based DPI technology is quickly becoming the preferred DPI drug delivery platform for pulmonary delivery. It provides drug stability advantages, encourages patient compliance and is cost-effective to manufacture with various dose carrying capacity. With more than 20 years of experience in manufacturing DPI- capsules, Lonza offers a uniquely customized portfolio of polymers to meet the growing need of inhalation DPI products for pulmonary drug delivery,” said Stef Vanquickenborne, vice president R&D, Lonza Pharma & Biotech.

 

The Capsugel Zephyr capsule portfolio aims to address comprehensive inhalation solutions that ensure end-product efficacy with consistent and optimal release performance regardless of formulation characteristics or DPI device principles. Lonza offers a full-service inhalation drug-delivery approach based on its particle engineering platforms, specialized encapsulation technologies as well as customized capsules for use with a large range of DPI devices. The portfolio is supported by a global integrated supply chain, quality and regulatory support and Lonza’s manufacturing network for associated services.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics